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www.sciencedirect.comOphthalmology provides a unique perspective on many
aspects of health; the eye is a window to many vascular,
inflammatory, genetic, and environmental conditions. The
vision specialist often carries the burden of managing the
end-organ effects of systemic disease such as diabetes,
rheumatoid arthritis, and hypertension. With diabetes in par-
ticular, ophthalmologists are acutely aware of the need for
prevention and cost-effective screening. However, there is
an epidemic of blindness that has enveloped much of the
world, and eye physicians are standing silently by. This
epidemic is the vision loss attributable to tobacco smoking.
The association of smoking with ocular disease is well
described.1 Most practicing ophthalmologists can readily
recall patients with smoking related diseases. The strong
association of tobacco abuse with Grave’s ophthalmopathy,
uveitis, and age-related macular degeneration are readily
apparent to the astute clinician. Tobacco smoking is also asso-
ciated with dysfunctional tear syndrome, cataracts, and likely
contributes directly to the development of diabetes mellitus.2
A survey of patients found that fear of blindness was a
prime concern,3 and it is established that the negative health
consequences of smoking are an important contributor to
smoking cessation.4 In fact, the fear of loss of vision was sec-
ond only to lung cancer as a potential motivating factor for
those considering quitting smoking. Given this overwhelming
evidence that suggests that fear of blindness could be an
important tool in promoting smoking cessation among
patients, it is given surprisingly little attention in the
ophthalmic community.5
In 2014 theUnited StatesDepartment of Health andHuman
Services published a report commemorating the 50th
anniversary of the landmark 1964 report that brought the
association of smoking and disease to the forefront. Dr. Boris
D. Lushniak, M.D., M.P.H., the acting surgeon general, stated:
‘‘It is my sincere hope that 50 years from now we won’t need
another Surgeon General’s report on smoking and health,
because tobacco-related disease and death will be a thing of
the past. Working together, we can make that vision a reality.’’6
Ophthalmologists, as physicians, should also be working
together to promote smoking cessation. Similar to many
other evidence-based interventions that are poorly adopted
in daily practice, this aspect of patient health has not received
adequate attention. We have a unique opportunity, and
obligation, to intervene in this preventable contributor to
blindness. The benefits to our patients could be tremendous,
and it is rare that we have such a powerful therapeutic option
that only carries the cost of changing our practice patterns.
It is likely that lack of training and awareness is a barrier to
implementing this paradigm; if the ophthalmologist could
simply prescribe ‘‘smoking cessation’’, uptake would likelybe swift. However, there are guidelines for brief clinical
interventions with smokers. The U.S. Public Health Service
has developed the ‘‘5 A’’ mnemonic for patient encounters7:
 ASK - about tobacco use at every encounter.
 ADVISE - to quit tobacco use in a clear manner.
 ASSESS - willingness to quit.
 ASSIST - in quitting.
 ARRANGE - follow-up to monitor progress.
The first 3 steps are readily adaptable to the ophthalmol-
ogists’ practice, and require very little time. The smoking
status of each patient should already be a standard part of
the patient history. For current smokers, a simple statement
alerting them to the potential adverse effects of smoking
on their vision may motivate them to consider cessation.
For those patients who report a willingness to quit, referral
should be made to a primary care provider for the final two
steps, which may include behavioral skills counseling,
pharmacotherapy, and group support. Many smokers require
multiple attempts at cessation, but the sooner we encourage
them to begin that journey the sooner we begin fighting the
ignored epidemic of blindness.
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